Table 1.
Gender | Age | Smoking | Clinical Symptoms | Diagnostic Procedure | Primary Disease | PaO2 mmHg |
|
---|---|---|---|---|---|---|---|
1 | Male | 38 | Current | Weight loss, weakness, night sweats | BALF | MDS-MLD | 64.1 |
2 | Female | 26 | Never | Fever, productive cough | CT guided percutaneous lung biopsy | TB | 94.5 |
3 | Male | 20 | Current | Exertional dyspnea, dry cough | Surgical biopsy | CML | 97.4 |
4 | Male | 26 | Never | Weakness, fever | BALF+TBLB | MDS-SLD | NA |
5 | Male | 37 | Never | Dyspnea, dry cough | BALF | MDS-U | 48 |
6 | Male | 33 | Never | Fever, weight loss, weakness | Surgical biopsy | MDS-EB | 34.6 |
7 | Male | 56 | Never | Fever, dry cough | VATS | TB | 84.1 |
8 | Female | 54 | Never | Weight loss,weakness, fever | CT guided percutaneous lung biopsy | TB | 39 |
9 | Female | 51 | Never | Dyspnea, productive cough | BALF | TB | 35.6 |
CT Scan Features | Comorbidity/Complication | Treatment | Outcomes | ||||
1 | diffused bilateral GGO | None | WLL, Danazol, Retinoic acid, | Die | |||
2 | bilateral GGO patchy geographic pattern, interlobular septal thickening,small scattered nodules | Hepatitis | INH, RIF, EMB, Levofloxacin | Recovery | |||
3 | bilateral GGO patchy geographic pattern, bilateral cysts | None | Hydroxyurea | NA | |||
4 | diffused bilateral GGO, small nodules | Type B viral hepatitis | Prednisone | Die | |||
5 | bilateral GGO with a crazy paving pattern,enlarged mediastinal lymph nodes | Mycobacterium cheloneiinfection | Antibiotics, traditional medicine | Die | |||
6 | diffused bilateral GGO, interlobular septal thickening,small scattered nodules | Hospital acquired pneumonia | Danazol, Retinoic acid, WLL | Die | |||
7 | bilateral GGO with a crazy paving pattern, interlobular septal thickening | None | INH, RIF, EMB,Clarithromycin, Oxifloxacin | Improved | |||
8 | diffused bilateral GGO, small scattered nodules | None | INH, RIF, EMB,Rifapentine | Stable | |||
9 | diffused bilateral GGO, septal thickening | Thrombopenia, Sjogren’s syndrome | INH, RIF, EMB,Levofloxacin, WLL | Improved |
BALF broncho-alverolar lavage fluid, CML chronic myelogenousleukemia;EMB ethambutol, GGO ground-glass opacities, INH isonicotinic acid hydrazide, MDS myelodysplastic syndrome(SLD:single lineage dysplasia; MLD: multilineage dysplasia; EB: excess blasts; U: unclassifiable), NA not available, RIF rifampicine, TB tuberculosis, TBLB transbronchial lung biopsy, VATS via video-assisted thoracic surgery, WLL whole lung lavage